What is the result of the meta-analysis of the RCTs regarding the survival benefit of the early invasive strategy?
The meta-analysis of the RCTs was inconclusive for a survival benefit of the early invasive strategy (OR:0.83[95%CI:0.64to1.09];P=0.180), and there were no significant differences in MI or major bleeding.